StockData
INNPFOTCPharmaceutical PreparationsFiscal year ends December 31

INNOCAN PHARMA Corp

$1.33+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

INNOCAN PHARMA Corp revenue by segment

No segment breakdown reported

Innocan Pharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.